DCT

2:24-cv-00264

Regeneron Pharma Inc v. Amgen Inc

General

Filed

01/10/24

Cause of ActionPatent Infringement

SectorBiotech

StatusClosed

Patent Owner

Operating Company

Nature of Suit830 Patent

Judge	Period	PO Win Rate
John W. Holcomb	--	55%

Plaintiff

Party

Name	Ratings
Regeneron Pharmaceuticals Inc	L2E

Attorney

Name	Ratings
Weil Gotshal & Manges LLP	L4C
Elizabeth Weiswasser	L5A
Anish Desai	L5A
Christopher Pepe	L4A
Priyata Patel	L3B
Natalie C. Kennedy	L3B
Matthew Sieger	L3C
Yi Zhang	L3D
Kathryn Leicht	L2C
Tom Yu	L1C
Kellie C. van Beck	L1C
Zhen Lin	L1C
Rocco Recce	L1D
Williams & Connolly LLP	L3C
David I. Berl	L5B
Thomas S. Fletcher	L5B
Ellen E. Oberwetter	L4A
Andrew V. Trask	L4B
Teagan J. Gregory	L3C
Shaun P. Mahaffy	L3C
Kathryn Kayali	L3C
Haylee B. Anderson	L2B
Renee M. Griffin	L2B
Jennalee Beazley	L2B
Adam Pan	L2B
Arthur J. Argall	L2C
Rebecca A. Carter	L1B
Kellogg Huber Hansen Todd Evans Figel PLLC	L2C
Jacob Hartman	L4B
Andrew Goldsmith	L2B
Bienert Katzman Littrell Williams LLPLocal	---- --
Anthony R. Bisconti	---- --
Umhofer Mitchell & King LLPLocal	----
Matthew D. Umhofer	---- --
Jonas P. Mann	---- --

Defendant

Party

Name	Ratings
Amgen USA Inc	L4A

Attorney